SlideShare a Scribd company logo
UNDER THE GUIDANCE OF:
Dr. T. VEDAVATHIM.PHARM, PhD
PHARMACOLOGICAL SCREENING OF
ANTI-ARRHYTHMIC DRUG
PRESENTED BY:-
RAKESH KUMAR
M.PHARMACY (PHARMACOLOGY)
1
CARDIAC ARRHYTHMIAS
Deviation from normal
• Origin/Conduction
• Rhythm
• Rate
2
CLASSIFICATION OF ARRHYTMIAS
• Normal heart rate – 60-100 beats/min
Based on the heart rate:
• Tachyarrhythmia - rapid heart beat - >100/min
• Bradyarrhythmia – slow heart beat - <60/min
3
SCREENING OF ANTI-ARRHYTHMICS
DRUG SCREENING:
Pre clinical testing of drugs in experimental
animals or in vitro for their biological and toxic
effects and potential clinical applications
The screening of anti-arrhythmics is done by two
different methods.
• In-vitro models
• In-vivo models
4
IN VIVO MODELS
• Chemically induced arrhythmia
• Electrically induced arrhythmia
• Exercise induced ventricular fibrillation
• Mechanically induced arrhythmia
• Genetically induced arrhythmia
•
•
•
•
•
5
CHEMICALLY INDUCED ARRHYTHMIA
• A large number of agents are capable of
inducing arrhythmias
• Administration of anesthetics like chloroform,
ether, halothane followed by a precipitating
stimulus such as adrenaline, ouabain alkaloids
cause arrhythmia
6
PURPOSE AND RATIONALE:
Aconitine – acts persistently on sodium
channels and activates them – ventricular
arrhythmias
REQUIREMENTS:
Animals - Male Ivanovas rats (300-400g)
Anesthetic – Urethane
Standard drug – Procainamide i.v (5mg/kg)
Lidocaine i.v (5mg/kg)
7
PROCEDURE
Animals – selected

Anesthetized


Test / std/control – administered
↓
Aconitine (5μg/kg +0.1N HNO₃) (administered through
saphenous vein)
↓
ECG – Recorded
8
•
•
•
•
•
•
EVALUATION
•Ventricular tachycardia
•Ventricular fibrillation
•Death
9
• Electrical stimulations – flutters and
fibrillation
REQUIREMENTS :
• Animals – adult dogs (8-12kg)
• Anesthetic – sodium pentobarbital (35mg/kg)
ELECTRICALLY INDUCED ARHYTHMIAS
10
PROCEDURE
Animal – selected
↓
Anesthetized
↓
Artificial respiration – Harvard respiratory pump
B.P – monitored
Body temperature – maintained by thermal blanket
↓
Chest cavity is opened
↓
Heart suspended in pericardial cradle
↓
11
↓
SA node – crushed
↓
For electric impulse – Ag-AgCl electrode embedded in a teflon
disc- sutured on left ventricle
↓
Test drug/ std/contol – femoral artery
↓
Constant current for 400ms is applied through electrode
↓
Recording elecrodes – surface of each ventricle
↓
12
Recording elecrodes – surface of each ventricle
↓
ECG – monitored
↓
VFT is measured (minimal current intensity required to induce
sustained ventricular fibrillation)
When VF occurs – heart is defibrillated – recovered
EVALUATION
Ventricular Fibrillation Threshold
13
EXERCISE INDUCED VENTRICULAR
FIBRILLATION
14
REQUIREMENTS
Animals – Mongrel dogs (15 -19 kg)
Anesthetic – Sodium pentobarbitone (10mg/kg) i.v.
SURGICAL PREPARATION
Animals – selected
↓
Anesthetized
↓
Chest cavity – opened
↓
Heart suspended in pericardial cradle
↓
around left artery – Doppler flow inducer- to measure blood
pressure _
hydraulic occluder – place to occlude coronary
artery
15
↓
Pair of insulated silver coated wires – sutured on left and right
ventricles- measure HR
↓
Occlusion of LAD
↓
Myocardial infarction
↓
After 24 hrs- test drug/std/control - administered
During this experiment:
• Transdermal fentanyl patch (↓post operative discomfort)
• Bupivacaine HCl
• Antibiotic therapy(amoxicillin)
16
3-4 weeks after the production of MI
↓
Animals – run on a motor –driven treadmill
↓
Work load - ↑every 3 min for total of 18 mins
↓
During last minute-treadmill is stopped- left
artery- occluded for 2 mins
↓
After 10-20 sec of VF – defibrillation is achieved without
any delay by placing large metal plates across animal’s
chest
EVALUATION:
HR is measured
17
MECHANICALLY INDUCED ARRHYTHMIA
Arrhythmias –induced directly by ischemia and
reperfusion
• Coronary artery ligation in anesthetized dog
results in:
↑ in HR
↑in heart contractility
↑ in BP
Ventricular arrhythmias
18
REQUIREMENTS
Animals – Dogs (20-25Kg)
Anesthetic – Thiobutobarbital sodium (30mg/kg)
PROCEDURE:
Animals – selected
↓
Anesthetized
↓
Artificial respiration – positive pressure respirator
↓
Femoral artery – cannulated and connected to pressure transducer
↓
Chest cavity –opened
LAD is exposed
↓
19
Silk suture is placed around LAD
↓
After 45 min(equilibration) – test/std/control-
administered through saphenous vein
↓
After 20 min- ligature of coronary artery is closed for 90
min
↓
Occlusion released – reperfusion period maintained for
30 min.
• All the parameters – recorded
• At the end – surviving animals are sacrificed by an
overdose of Pentobarbital sodium
20
EVALUATION
• Mortality
• Hemodynamics
• Heart rate
21
22

More Related Content

What's hot

Screening of anti-emetic drugs
Screening of anti-emetic drugsScreening of anti-emetic drugs
Screening of anti-emetic drugs
Dr. Prashant Shukla
 
Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...
SuchiJain7
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agents
SwaroopaNallabariki
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agent
Jaineel Dharod
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugsBindu Pulugurtha
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
Dr Roohana Hasan
 
Screening of Antidiabetics
Screening of AntidiabeticsScreening of Antidiabetics
Screening of Antidiabetics
Sayli Chaudhari
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
Prajitha p
 
Anti diarrheal & laxatives
Anti diarrheal & laxativesAnti diarrheal & laxatives
Anti diarrheal & laxatives
Jaineel Dharod
 
Screening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsScreening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive Agents
Dr. Advaitha MV
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
Rajeshwar Yadav
 
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsPreclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Chetan Prakash
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
Jaineel Dharod
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
SONALPANDE5
 
Preclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer'sPreclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer's
Drx Burade
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
Dr Roohana Hasan
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agentsKanthlal SK
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Abdul Hameed
 
Preclinical screening of anti anginals
Preclinical screening of anti anginalsPreclinical screening of anti anginals
Preclinical screening of anti anginals
Dekollu Suku
 

What's hot (20)

Screening of anti-emetic drugs
Screening of anti-emetic drugsScreening of anti-emetic drugs
Screening of anti-emetic drugs
 
Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agents
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agent
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugs
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
 
Screening of Antidiabetics
Screening of AntidiabeticsScreening of Antidiabetics
Screening of Antidiabetics
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
 
Anti diarrheal & laxatives
Anti diarrheal & laxativesAnti diarrheal & laxatives
Anti diarrheal & laxatives
 
Screening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsScreening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive Agents
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
 
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsPreclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
Preclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer'sPreclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer's
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agents
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Preclinical screening of anti anginals
Preclinical screening of anti anginalsPreclinical screening of anti anginals
Preclinical screening of anti anginals
 

Similar to Pharmacological screening of anti arrhythmic drug

sceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdfsceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdf
Apurva Pawar
 
PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...
PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...
PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...
Dr Pankaj Kumar Gupta
 
Antiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptxAntiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptx
sharanuGurikar
 
Evaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmicsEvaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmics
Dr Nikita Ingale
 
Evaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugsEvaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugs
shaffain
 
anti arrhythmic drugs anaesthesiology cardiac
anti arrhythmic drugs anaesthesiology  cardiacanti arrhythmic drugs anaesthesiology  cardiac
anti arrhythmic drugs anaesthesiology cardiac
NeelkantRaju
 
Approach to Palpitation.pptx
Approach to Palpitation.pptxApproach to Palpitation.pptx
Approach to Palpitation.pptx
waizury
 
Antihypertensive and antidiarrhoeal drugs preclinical screening
Antihypertensive and antidiarrhoeal drugs preclinical screeningAntihypertensive and antidiarrhoeal drugs preclinical screening
Antihypertensive and antidiarrhoeal drugs preclinical screening
DHINESHKUMAR V
 
ANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptxANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptx
NeelkantRaju
 
Basic hemodynamic monitoring for nurses
Basic hemodynamic monitoring for nurses Basic hemodynamic monitoring for nurses
Basic hemodynamic monitoring for nurses
Muhammad Asim Rana
 
Anticoagulants.pptx
Anticoagulants.pptxAnticoagulants.pptx
Anticoagulants.pptx
Mazhar Ayub (NIPER)
 
Guidelines for management of acute stroke
Guidelines for management of acute strokeGuidelines for management of acute stroke
Guidelines for management of acute stroke
sankalpgmc8
 
Cardiopulmonary Cerebral Resuscitation (CPCR)
Cardiopulmonary Cerebral Resuscitation (CPCR) Cardiopulmonary Cerebral Resuscitation (CPCR)
Cardiopulmonary Cerebral Resuscitation (CPCR)
upstatevet
 
Antihypertensive Screening Models
Antihypertensive Screening ModelsAntihypertensive Screening Models
Antihypertensive Screening Models
VishnuPrabhakar26
 
Cpr 2010
Cpr 2010Cpr 2010
Cpr 2010
Sanil Varghese
 
screening method of cardiovascular activity
screening method of cardiovascular activityscreening method of cardiovascular activity
screening method of cardiovascular activity
ArpitSuralkar
 
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptxPreclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Ashish Kumar Jha
 
Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2shayiamk
 

Similar to Pharmacological screening of anti arrhythmic drug (20)

sceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdfsceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdf
 
acls
aclsacls
acls
 
PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...
PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...
PH1.27 Describe the mechanisms of action, types, doses, side effects, indicat...
 
Antiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptxAntiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptx
 
Evaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmicsEvaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmics
 
Evaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugsEvaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugs
 
anti arrhythmic drugs anaesthesiology cardiac
anti arrhythmic drugs anaesthesiology  cardiacanti arrhythmic drugs anaesthesiology  cardiac
anti arrhythmic drugs anaesthesiology cardiac
 
Approach to Palpitation.pptx
Approach to Palpitation.pptxApproach to Palpitation.pptx
Approach to Palpitation.pptx
 
Antihypertensive and antidiarrhoeal drugs preclinical screening
Antihypertensive and antidiarrhoeal drugs preclinical screeningAntihypertensive and antidiarrhoeal drugs preclinical screening
Antihypertensive and antidiarrhoeal drugs preclinical screening
 
ANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptxANTIARRHYTHMICS.pptx
ANTIARRHYTHMICS.pptx
 
Basic hemodynamic monitoring for nurses
Basic hemodynamic monitoring for nurses Basic hemodynamic monitoring for nurses
Basic hemodynamic monitoring for nurses
 
Anticoagulants.pptx
Anticoagulants.pptxAnticoagulants.pptx
Anticoagulants.pptx
 
Guidelines for management of acute stroke
Guidelines for management of acute strokeGuidelines for management of acute stroke
Guidelines for management of acute stroke
 
Cpr 2010
Cpr 2010Cpr 2010
Cpr 2010
 
Cardiopulmonary Cerebral Resuscitation (CPCR)
Cardiopulmonary Cerebral Resuscitation (CPCR) Cardiopulmonary Cerebral Resuscitation (CPCR)
Cardiopulmonary Cerebral Resuscitation (CPCR)
 
Antihypertensive Screening Models
Antihypertensive Screening ModelsAntihypertensive Screening Models
Antihypertensive Screening Models
 
Cpr 2010
Cpr 2010Cpr 2010
Cpr 2010
 
screening method of cardiovascular activity
screening method of cardiovascular activityscreening method of cardiovascular activity
screening method of cardiovascular activity
 
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptxPreclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
 
Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2Pharmacology dysrhythmias 2
Pharmacology dysrhythmias 2
 

Recently uploaded

platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
zeex60
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
yusufzako14
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
ronaldlakony0
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
nodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptxnodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptx
alishadewangan1
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
David Osipyan
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
yqqaatn0
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdfMudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
frank0071
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 

Recently uploaded (20)

platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
S.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary levelS.1 chemistry scheme term 2 for ordinary level
S.1 chemistry scheme term 2 for ordinary level
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
nodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptxnodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptx
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdfMudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
Mudde & Rovira Kaltwasser. - Populism - a very short introduction [2017].pdf
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 

Pharmacological screening of anti arrhythmic drug

  • 1. UNDER THE GUIDANCE OF: Dr. T. VEDAVATHIM.PHARM, PhD PHARMACOLOGICAL SCREENING OF ANTI-ARRHYTHMIC DRUG PRESENTED BY:- RAKESH KUMAR M.PHARMACY (PHARMACOLOGY) 1
  • 2. CARDIAC ARRHYTHMIAS Deviation from normal • Origin/Conduction • Rhythm • Rate 2
  • 3. CLASSIFICATION OF ARRHYTMIAS • Normal heart rate – 60-100 beats/min Based on the heart rate: • Tachyarrhythmia - rapid heart beat - >100/min • Bradyarrhythmia – slow heart beat - <60/min 3
  • 4. SCREENING OF ANTI-ARRHYTHMICS DRUG SCREENING: Pre clinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications The screening of anti-arrhythmics is done by two different methods. • In-vitro models • In-vivo models 4
  • 5. IN VIVO MODELS • Chemically induced arrhythmia • Electrically induced arrhythmia • Exercise induced ventricular fibrillation • Mechanically induced arrhythmia • Genetically induced arrhythmia • • • • • 5
  • 6. CHEMICALLY INDUCED ARRHYTHMIA • A large number of agents are capable of inducing arrhythmias • Administration of anesthetics like chloroform, ether, halothane followed by a precipitating stimulus such as adrenaline, ouabain alkaloids cause arrhythmia 6
  • 7. PURPOSE AND RATIONALE: Aconitine – acts persistently on sodium channels and activates them – ventricular arrhythmias REQUIREMENTS: Animals - Male Ivanovas rats (300-400g) Anesthetic – Urethane Standard drug – Procainamide i.v (5mg/kg) Lidocaine i.v (5mg/kg) 7
  • 10. • Electrical stimulations – flutters and fibrillation REQUIREMENTS : • Animals – adult dogs (8-12kg) • Anesthetic – sodium pentobarbital (35mg/kg) ELECTRICALLY INDUCED ARHYTHMIAS 10
  • 11. PROCEDURE Animal – selected ↓ Anesthetized ↓ Artificial respiration – Harvard respiratory pump B.P – monitored Body temperature – maintained by thermal blanket ↓ Chest cavity is opened ↓ Heart suspended in pericardial cradle ↓ 11
  • 12. ↓ SA node – crushed ↓ For electric impulse – Ag-AgCl electrode embedded in a teflon disc- sutured on left ventricle ↓ Test drug/ std/contol – femoral artery ↓ Constant current for 400ms is applied through electrode ↓ Recording elecrodes – surface of each ventricle ↓ 12
  • 13. Recording elecrodes – surface of each ventricle ↓ ECG – monitored ↓ VFT is measured (minimal current intensity required to induce sustained ventricular fibrillation) When VF occurs – heart is defibrillated – recovered EVALUATION Ventricular Fibrillation Threshold 13
  • 14. EXERCISE INDUCED VENTRICULAR FIBRILLATION 14 REQUIREMENTS Animals – Mongrel dogs (15 -19 kg) Anesthetic – Sodium pentobarbitone (10mg/kg) i.v.
  • 15. SURGICAL PREPARATION Animals – selected ↓ Anesthetized ↓ Chest cavity – opened ↓ Heart suspended in pericardial cradle ↓ around left artery – Doppler flow inducer- to measure blood pressure _ hydraulic occluder – place to occlude coronary artery 15
  • 16. ↓ Pair of insulated silver coated wires – sutured on left and right ventricles- measure HR ↓ Occlusion of LAD ↓ Myocardial infarction ↓ After 24 hrs- test drug/std/control - administered During this experiment: • Transdermal fentanyl patch (↓post operative discomfort) • Bupivacaine HCl • Antibiotic therapy(amoxicillin) 16
  • 17. 3-4 weeks after the production of MI ↓ Animals – run on a motor –driven treadmill ↓ Work load - ↑every 3 min for total of 18 mins ↓ During last minute-treadmill is stopped- left artery- occluded for 2 mins ↓ After 10-20 sec of VF – defibrillation is achieved without any delay by placing large metal plates across animal’s chest EVALUATION: HR is measured 17
  • 18. MECHANICALLY INDUCED ARRHYTHMIA Arrhythmias –induced directly by ischemia and reperfusion • Coronary artery ligation in anesthetized dog results in: ↑ in HR ↑in heart contractility ↑ in BP Ventricular arrhythmias 18
  • 19. REQUIREMENTS Animals – Dogs (20-25Kg) Anesthetic – Thiobutobarbital sodium (30mg/kg) PROCEDURE: Animals – selected ↓ Anesthetized ↓ Artificial respiration – positive pressure respirator ↓ Femoral artery – cannulated and connected to pressure transducer ↓ Chest cavity –opened LAD is exposed ↓ 19
  • 20. Silk suture is placed around LAD ↓ After 45 min(equilibration) – test/std/control- administered through saphenous vein ↓ After 20 min- ligature of coronary artery is closed for 90 min ↓ Occlusion released – reperfusion period maintained for 30 min. • All the parameters – recorded • At the end – surviving animals are sacrificed by an overdose of Pentobarbital sodium 20
  • 22. 22